Our teaching programs

Prof. Markus Ketteler, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the kidneys

Prof. Andreas Hartkopf, MD, Clinic for Gynecology and Obstetrics at the University Hospital Ulm
Physiology and pathophysiology of the breast 

Prof. Peter Ong, MD, and Astrid Hubert, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the cardiovascular System

Prof. Kilian Rapp, MD, Robert Bosch Hospital, Stuttgart
Grundbegriffe der Geriatrie einschließlich besonderer Aspekte der Pharmakotherapie bei gebrechlichen Menschen 

Prof. Claus Neurohr, MD, RBK Lung Center Stuttgart, Clinic Schillerhöhe GmbH
Physiology and pathophysiology of the lung

Robyn Laura Kosinsky, PhD, Robert Bosch Center of  Tumor Diseases, Stuttgart
Intestinal inflammation and tumorigenesis –Pathogenesis, molecular classification and experimental tools

Prof. Marc Dahlke, MD, Robert Bosch Hospital, Stuttgart
Metastatic Disease from a Surgeons Perspective 

Nikolaus Lubomierski, MD, Robert Bosch Hospital, Stuttgart
Novel Classification and Treatment of Diabetes Mellitus

Prof. Jörg Albert, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the gastrointestinal tract

Christian Schäfer, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the liver 

Prof. Olaf Rieß, MD, University Hospital, Tuebingen
Diagnostics of Rare Diseases: Beyond The Exome 

Prof. Uwe Fuhr, MD, University Hospital of the University of Cologne(BfR)
Pharmacokinetics

Prof. Volker Lauschke, PhD, Karolinska Institute, Stockholm
Inter-individual Differences in Drug Response - From Computational Predictions to Experimental Models 

Prof. Thomas Wider, MD, University Medical Center Tübingen
Immune Senescence Surveillance of Tumours 

Prof. German Ott, MD, Robert Bosch Hospital, Stuttgart
Diagnostic Pathology: A Method Bridging Classical Morphology and Molecular Genetics

Prof. Michael Schwarz, MD, University Hospital Tübingen
Mechanisms of Tumor Promotion  

Christina Justenhoven, PhD, Bioscientia - Institute of Medical Diagnostic GmbH, Ingelheim
Analysis of DNA variations  

Prof. Marius Üffing, PhD, University Tübingen
Proteomics - From basic approaches to clinical applications  

Prof. Albert Bräuning, PhD, German Federal Institute for Risk Assessment (BfR)
Food Safety at the German Federal Institute for Risk Assessments

Prof. Uwe Fuhr, MD, University Hospital of the University of Cologne
Pharmacokinetics - Basic Principles  

Prof. Klaus Mörike, MD, University Hospital Tübingen
Clinical Studies – Design and Realization 

Pavel Bashtrykov, PhD, University Stuttgart
Epigenetic silencing of oncogenes: a novel approach for targeted cancer therapy

Prof. Joerg Albert, MD, Robert Bosch Hospital
Physiology and pathophysiology of the digestive system

Christian Schäfer, MD, Robert Bosch Hospital
Physiology and pathophysiology of the liver  

Prof. Jun J. Yang, Ph.D., St. Jude Children's Research Hospital
Pharmacogenomics of Thiopurines and Precision Medicine: From Genomics to Clinical Actions 

Prof. Godehard Friedel, MD, Robert Bosch Hospital - Schillerhoehe
Physiology and pathophysiology of the lungs

Prof. Andreas Hartkopf, MD, University Hospital Tuebingen)
Physiology and pathophysiology of the breast

Prof. Kilian Rapp, MD, Robert Bosch Hospital
Physiological Specialties in Elderly Patients  

Prof. Peter Ong, MD, Robert Bosch Hospital
Physiology and pathophysiology of the cardiovascular System  

Prof. Robert Feil, PhD, University of Tuebingen
Seeing is believing: Combining biochemistry and mouse genetics to visualize physiology, pathophysiology and pharmacology

Martin Kimmel, MD, Robert Bosch Hospital
Physiology and pathophysiology of the kidneys

Prof. Andreas Nüssler, MD, University of Tuebingenm
Cell culture approaches towards 3D micro-organ Engineering  

Prof. Sven Glaesker, MD, University Hospital Brussels
Molecular and morphological pathogenesis in von Hippel-Lindau (VHL) disease 

Prof. Klaus Moerike, MD, University Hospital Tuebingen
Arzneimitteltherapie kardialer Arrhythmien

Prof. Robert Lukowski, PhD, University Hospital Tuebingen
The NO-cGMP system: Implications for disease biology and therapy

Reinhold Kerb, MD, CRS Clinical Research GmbHm
Drug Therapy of Diabetes, Obesity, Metabolic Syndrome  

Prof. Peter Muenzel, University of Tuebingen
Gifte und Vergiftungen  

Prof. Carsten Gruellich, MD, NCT -National Center for Tumor Diseases Heidelberg Medical Oncology
Molekulare Heterogenität und therapiegetriebene Evolution des Nierenzellkarzinoms

Markus Morkel, MD, Charité - University Hospital Berlin
Organoids as a tool to assess oncogene characteristics and cancer signaling networks

Prof. Robert Juette, PhD, Institute of the History of Medicine, Robert Bosch Stiftung
Der Placebo Effekt: Past and Present